In vitro inhibition and induction of human hepatic cytochrome P450 enzymes by modafinil

Drug Metabolism and Disposition

Volumn 28, Issue 6, 2000, Pages 664-671

  Robertson, Philmore ^a   Decory, Heleen H ^a,c   Madan, Ajay ^b   Parkinson, Andrew ^b  

^a CEPHALON INC   (United States)

^b XenoTech LLC   (United States)

^c UNIVERSITY OF ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 2C19; CYTOCHROME P450 3A4; LIVER ENZYME; MEPHENYTOIN; MODAFINIL; PHENACETIN O DEETHYLASE;

ARTICLE; CONTROLLED STUDY; DRUG METABOLISM; ENZYME ASSAY; ENZYME INACTIVATION; ENZYME INDUCTION; ENZYME SUBSTRATE; HUMAN; HUMAN CELL; LIVER MICROSOME; NARCOLEPSY; PRIORITY JOURNAL; SOMNOLENCE;

BENZHYDRYL COMPOUNDS; CENTRAL NERVOUS SYSTEM STIMULANTS; CYTOCHROME P-450 ENZYME SYSTEM; ENZYME INDUCTION; HUMANS; LIVER;

EID: 0034048206     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Bertz RJ and Granneman GR (1997) Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions. Clin Pharmacokinet 32:210-258.
2. Boivin DB, Montplaisir J, Petit D, Lambert C and Lubin S (1993) Effects of modafinil on symptomatology of human narcolepsy. Clin Neuropharmacol 16:46-53.
3. Brøsen K (1995) Drug interactions and the cytochrome P450 system: The role of cytochrome P450 1A2. Clin Pharmacokinet 29 (Suppl 1):20-25.
4. Buters JTM, Schiller CD and Chou RC (1993) A highly sensitive tool for the assay of cytochrome P450 enzyme activity in rat, dog and man: Direct fluorescence monitoring of the deethylation of 7-ethoxy-4-trifluoromethylcoumarin. Biochem Pharmacol 46:1577-1584.
5. Cresteil T, Monsarrat B, Alvinerie P, Tréluyer JM, Vieira I and Wright M (1994) Taxol metabolism by human liver microsomes: Identification of cytochrome P450 isozymes involved in its biotransformation. Cancer Res 54:386-392.
6. Eichelbaum M (1984) Polymorphic drug oxidation in humans. Fed Proc 43:2298-2302.
7. Flockhart DA (1995) Drug interactions and the cytochrome P450 system: The role at cytochrome P450 2C19. Clin Pharmacokinet 29 (Suppl 1):45-52.
8. Goldstein JA, Faletto MB, Romkes-Sparks M, Sullivan T, Kitareewan S, Raucy JL, Lasker JM and Ghanayem BI (1994) Evidence that CYP2C19 is the major (S)-mephenytoin 4′-hydroxylase in humans. Biochemistry 33:1743-1752.
9. Grözinger M, Härtter S, Hiemke C, Griese E-U and Röschke J (1998) Interaction of modafinil and clomipramine as comedication in a narcoleptic patient. Clin Neuropharmacol 21:127-129.
10. Guengerich FP (1995) Human cytochrome P450 enzymes, in Cytochrome P450. Structure, Mechanism and Biochemistry, 2nd ed. (Ortiz de Montellano PR ed) pp 473-535, Plenum Press, New York.
11. m diazepam N-demethylases. Drug Metab Dispos 25:133-139.
12. Ko J-W, Sukhova N, Thacker D, Chen P and Rockhart DA (1997) Evaluation of omeprazole and lansoprazole as inhibitors of cytochrome P450 isoforms. Drug Metab Dispos 25:853-862.
13. Le Cacheux P, Charasse C, Mourtada R, Muh P, Boulahrouz R and Simon P (1997) Syndrome de Gélineau chez une transplantée rénale: Mise en évidence d'une interaction ciclosporine-modafinil [Gélineau's syndrome in a kidney transplant patient: Observation of a cyclosporine-modafinil interaction]. Presse Méd 26:466.
14. LeCluyse EL, Audus KL and Hochman JH (1994) Formation of extensive canalicular networks by rat hepatocytes cultured in collagen-sandwich configuration. Am J Physiol 266:C1764-C1774.
15. LeCluyse EL, Bullock PL, Parkinson A and Hochman JH (1996) Cultured rat hepatocytes, in Models for Assessing Drug Absorption and Metabolism (Borchardt RT, Smith PL and Wilson G eds) pp 121-159, Plenum Press, New York.
16. Leemann T, Transon C and Dayer P (1993) Cytochrome P450TB (CYP2C): A major monooxygenase catalyzing diclofenac 4′-hydroxylation in human liver. Life Sci 52:29-34.
17. Madan A, Dehaan R, Mudra D, Carroll K, LeCluyse E and Parkinson A (1999) Effect of cryopreservation on cytochrome P-450 enzyme induction in cultured rat hepatocytes. Drug Metab Dispos 27:327-335.
18. Moachon G, Kanmacher I, Clenet M and Matinier D (1996) Pharmacokinetic profile of modafinil. Drugs Today 32:327-337.
19. Nielsen KK, Brøsen K, Gram LF and the Danish University Antidepressant Group (1992) Steady-state plasma levels of clomipramine and its metabolites: Impact of the sparteine/ debrisoquine oxidation polymorphism. Eur J Clin Pharmacol 43:405-411.
20. Nielsen KK, Flinois JP, Beaune P and Brøsen K (1996) The biotransformation of clomipramine in vitro, identification of the cytochrome P450s responsible for the separate metabolic pathways. J Pharmacol Exp Ther 277:1659-1664.
21. Parkinson A (1996) Biotransformation of xenobiotics, in Casarett and Doull's Toxicology: The Basic Science of Poisons, 5th ed. (Klaassen CD ed) pp 113-186, McGraw-Hill, New York.
22. Pearce RE, McIntyre CJ, Madan A, Sanzgiri U, Draper AJ, Bullock PL, Cook DC, Burton LA, Latham J, Nevins C and Parkinson A (1996a) Effects of freezing, thawing, and storing human liver microsomes on cytochrome P450 activity. Arch Biochem Biophys 331:145-169.
23. Pearce RE, Rodrigues AD, Goldstein JA and Parkinson A (1996b) Identification of the human P450 enzymes involved in lansoprazole metabolism. J Pharmacol Exp Ther 277:805-816.
24. Quistorff B, Dich J and Grunnet N (1989) Preparation of isolated rat liver hepatocytes, in Methods in Molecular Biology. Vol 5: Animal Cell Culture (Pollard JW and Walker JM eds) pp 151-160, Humana Press, Clifton, NJ.
25. Rendic S and Di Carlo FJ (1997) Human cytochrome P450 enzymes: A status report summarizing their reactions, substrates, inducers, and inhibitors. Drug Metab Rev 29:413-580.
26. Rettie AE, Korzekwa KR, Kunze KL, Lawrence RF, Eddy AC, Aoyama T, Gelboin HV, Gonzalez FJ and Trager WF (1992) Hydroxylation of warfarin by human cDNA-expressed cytochrome P-450: A role for P-4502C9 in the etiology of (S)-warfarin-drug interactions. Chem Res Toxicol 5:54-59.
27. Richheimer SL, Tinnermeier DM and Timmons DW (1992) High-performance liquid chromatographic assay of taxol. Anal Chem 64:2323-2326.
28. Seglen PO, Gordon PB and Poli A (1980) Amino acid inhibition of the autophagic/lysosomal pathway of protein degradation in isolated rat hepatocytes. Biochim Biophys Acta 630:103-118.
29. Seliabudy R, Kusaka M, Chiba K, Darmansjah I and Ishizaki T (1994) Dapsone N-acetylation, metoprolol α-hydroxylation, and S-mephenytoin 4-hydroxylation polymorphisms in an Indonesian population: A cocktail and extended phenotyping assessment trial. Clin Pharmacol Ther 56:142-153.
30. Shimada T, Yamazaki H, Mimura M, Inui Y and Guengerich FP (1994) Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: Studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 270:414-423.
31. Tassaneeyakul W, Birkett DJ, Veronese ME, McManus ME, Tukey RH, Quattrochi LC, Gelboin HV and Miners JO (1993) Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2. J Pharmacol Exp Ther 265:401-407.
32. Todhunter JA (1979) Reversible enzyme inhibition. Methods Enzymol 63:383-411.
33. Ward SA, Walle T, Walle UK, Wilkinson GR and Branch RA (1989) Propranolol's metabolism is determined by both mephenytoin and debrisoquin hydroxylase activities. Clin Pharmacol Ther 45:72-79.
34. Wong YN, Simcoe D, Hartman LN, Laughton WB, King SP, McCormick GC and Grebow PE (1999) A double-blind, placebo-controlled, ascending-dose evaluation of pharmacokinetics and tolerability of modafinil tablets in healthy male volunteers. J Clin Pharmacol 39:30-40.
35. Wright JD, Helsby NA and Ward SA (1995) The role of S-mephenytoin hydroxylase (CYP2C19) in the metabolism of the antimalarial biguanides. Br J Clin Pharmacol 39:441-444.